DESIGN, SYNTHESIS AND PRELIMINARY PHARMACOLOGICAL EVALUATION OF NEW METFORMIN DERIVATIVES
DOI:
https://doi.org/10.22159/ijpps.2017v9i1.15250Keywords:
Metformin, Intestinal ditripeptide transporter, Amino acids, In vivo antidiabetic studyAbstract
Objective: The purpose of this work was to enhance oral bioavailability of metformin by incorporation of different amino acid residues through the glycolic acid spacer.
Methods: Two series of metformin derivatives (V a-e) and (VI a-e) were synthesized by incorporation of five amino acids (glycine, alanine, phenylalanine, proline and GABA amino butyric acid) and their methyl esters respectively into metformin through glycolic acid spacer and preliminary evaluation for the antihyperglycemic activity was carried out using streptozotocin-induced diabetic rats model.
Results: In vivo anti-hyperglycemic activity of the final compounds (V a-e) and (VI a-e) showed that compounds (V b, V c, VI c and V e) produced higher percent of decrease in blood glucose level compared to metformin after 5 h of the treatment while compounds (VI b, VI c, V d, VI d, V e and VI e) showed profound effect after 24 h of the treatment. Although compounds (V a, VI a, V b and V c) showed a significant decrease in blood glucose level at 5 h but their effect diminished at 24 h. Compound (V e) showed higher anti-hyperglycemic effect than metformin and its effect continued up to 24 h.
Conclusion: From this study, it was concluded that incorporation of these amino acids or their methyl esters maintained or enhanced the antihyperglycemic effect of metformin.Â
Downloads
References
Koyagura Narendar, M Nagendra Nayak, MG Jamadar, Ashok M Patil, Sanjit Anand. Comparison of the effect of Pterocarpus Marsupium with Pioglitazone in dexamethasone-induced insulin resistance. Asian J Pharm Clin Res 2016;9 Suppl 2:211-4.
Lashen H. Role of metformin in the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab 2010;1:117–28.
Batchuluun B, Sonoda N, Takayanagi R, Inoguchi T. The cardiovascular effects of metformin: conventional and new Insights. Endocrinol Diabetes Obes 2014;2:1035.
Mullugeta Y, Chawla R, Kebede T, Worku Y. Dyslipidemia associated with a poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation. Indian J Clin Biochem 2012;27:363–9.
Kasznicki J, Sliwinska A, Drzewoski J. Metformin in cancer prevention and therapy. Ann Transl Med 2014;2:57.
Abbas HK, Al-bayati NJ, Gatea AJ. Effect of vitamin D, metformin on metabolic syndrome in polycystic ovarian syndrome patient. Am J Pharmacol Sci 2015;15:1.
Viollet B, Guigas B, Garcia NS, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 2012;122:253–70.
Rojas LBA, Gomes MB. Metformin: an old but still the best treatment for type 2 diabetes. Diabetol Metab Syndr 2013;5:6.
McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetologia 2016;59:426–35.
Brodin B, Nielsen CU, Steffansen B, Frøkjær S. Transport of peptidomimetic drugs by the intestinal Di/tripeptide transporter, PepT1. Pharmacol Toxicol 2002;90:285–96.
Freeman HJ. Clinical relevance of intestinal peptide uptake. World J Gastrointest Pharmacol Ther 2015;6:22–7.
Wenzel U, Thwaites DT, Daniel H. Stereoselective uptake of beta-lactam antibiotics by the intestinal peptide transporter. Br J Pharmacol 1995;116:3021-7.
Orellana IG. Strategies to improve oral drug bioavailability. Expert Opin Drug Delivery 2005;2:419-33.
Moffat AC, Osselton MD, Widdop B. Clark's analysis of drugs and poisons. (4th ed.). Pharmaceutical press. UK; 2011. p. 614.
Dhaneshwar SR, Salunkhe JV, Bhusari VK. Validated HPTLC method for simultaneous estimation of metformin hydrochloride, atorvastatin and glimepiride in bulk drug and formulation. J Anal Bioanal Techniques 2010;1:1000-109.
Ashraf Z, Imran M, Amin S. Synthesis, characterization and in vitro hydrolysis studies of ester and amide prodrugs of dexibuprofen. Med Chem Res 2012;21:3361-8.
Saeedi M, Goli F, Mahdavi M, Dehghan G, Faramarzi MA, Foroumadi A, et al. Synthesis and biological investigation of some novel sulfonamide and amide derivatives containing coumarin moieties. Iranian J Pharm Res 2014;13:881-92.
Talib AB, Mahdi MF, Mohammed MH. Design, synthesis, and hydrolysis study of mutual prodrugs of NASIDS with different antioxidants via a glycolic acid spacer. Pharm Globale 2012;2:0976-8157.
Naser NH, Mahdi MF, Omar TNA, Fadhil AA. Synthesis and preliminary pharmacological evaluation of new analogues of diclofenac as potential anti-inflammatory agents. Iraqi J Pharm Sci 2011;20:25-32.
Somanatha Jena, Ram C Jena, Rasmita Bhol, Khusbu Agarwal, Ansuman Sarangi, Pramod k Sahu, et al. A comparative study of the anti-oxidative and anti-diabetic potential of in vitro and in vivo root and leaf extract of Withania Somnifera on streptozotocin-induced diabetic rats. Int J Pharm Pharm Sci 2016;8.
Krishnarth N, Bisht A, Verma S, Sharma B. Design, synthesis of guanidine derivatives and their anti-hyperglycemic evaluation. Der Pharm Chem 2013;5:59-66.
Saleh DO, Bayoumi AR, El-Eraky WI, El-Khatib AS. Streptozotocin-induced vascular and biochemical changes in rats: effects of rosiglitazone vs. metformin. Bull Faculty Pharm Cairo University 2013;51:131–8.
Suresha RN, Ashwini V, Pragathi B, Kalabharathi HL, Satish AM, Pushpa VH, et al. The effect of carvedilol on blood glucose levels in normal albino rats. J Clin Diagnostic Res 2013;7:1900-3.
Papanas N, Maltezos E. Metformin: a review of its use in the treatment of type 2 diabetes. Clin Med Ther 2009;1:1367–81.
Sun J, Dahan A, Amidon GL. Enhancing the intestinal absorption of molecules containing the polar guanidino functionality: a double-targeted prodrug approach. Med Chem 2010;53:624–32.
Jing Sun, Arik Dahan, Gordon L Amidon. Enhancing the intestinal absorption of molecules containing the polar guanidino functionality: a double-targeted prodrug approach. J Med Chem 2010;53:624–32.
Ikumi Tamai, Takeo Nakanishi, Haruki Nakahara, Yoshimich Sai, Vadivel Ganapathy, Frederick H Leibach, et al. Improvement of L-Dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1. J Pharm Sci 1998; 87:1542-6.
Published
How to Cite
Issue
Section
